Volume 14, Number 9—September 2008
Underreported Threat of Multidrug-Resistant Tuberculosis in Africa
|Factor||Average, presurvey years
||Average, postsurvey years
|Coefficient||p value†||Coefficient||p value†|
|Case detection rate (new ss+)
|Year 2005 only variables|
|HIV/TB co-infection (%)||–0.09||0.593|
|Male/female ratio: case notifications||–0.05||0.787|
|Health expenditures (US $ per capita)||–0.01||0.956|
*TB, tuberculosis; MDR TB, multidrug-resistant TB; ss+, sputum sample positive.
†Marginally statistically significant trend (p<0.10).
‡Statistically significant trend (p<0.05).
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.